ARTICLE | Clinical News
GSK-923295: Phase I data
October 27, 2008 7:00 AM UTC
Additional preliminary data from an ongoing, dose-escalation Phase I trial in 11 patients with refractory advanced solid tumors showed that 1 patient with hepatoma experienced 6 months of stable disea...